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Liquid Sucrose Consumption Promotes Obesity and Impairs
Glucose Tolerance Without Altering Circulating Insulin Levels
Susan J. Burke1, Heidi M. Batdorf1, Thomas M. Martin1, David H. Burk1, Robert C. Noland1, Christopher R. Cooley2,
Michael D. Karlstad2, William D. Johnson1, and J. Jason Collier 1
Objective: Multiple factors contribute to the rising rates of obesity and to difficulties in weight reduction
that exist in the worldwide population. Caloric intake via sugar-sweetened beverages may be influential.
This study tested the hypothesis that liquid sucrose intake promotes obesity by increasing serum insulin
levels and tissue lipid accumulation.
Methods: C57BL/6J mice were given 30% sucrose in liquid form. Changes in weight gain, body compo-
sition, energy expenditure (EE), and tissue lipid content were measured.
Results: Mice drinking sucrose gained more total body mass (TBM), had greater fat mass, and displayed
impaired glucose tolerance relative to control mice. These metabolic changes occurred without altera-
tions in circulating insulin levels and despite increases in whole body EE. Lipid accrued in liver, but not
skeletal muscle, of sucrose-consuming mice. Oxygen consumption (VO2) correlated with fat-free mass
and moderately with TBM, but not with fat mass. ANCOVA for treatment effects on EE, with TBM, VO2,
lean body mass, and fat-free mass taken as potential covariates for EE, revealed VO2 as the most signifi-
cant correlation.
Conclusions: Weight gain induced by intake of liquid sucrose in mice is associated with lipid accrual in
liver, but not skeletal muscle, and occurs without an increase in circulating insulin.
Obesity (2018) 26, 1188–1196. doi:10.1002/oby.22217
Introduction
Obesity is a continually increasing major public health problem
worldwide (1) and is a major comorbidity for other disorders, includ-
ing cancer, diabetes, heart disease, and hypertension (2). Higher BMI
values disproportionally contribute to rising health care costs (3).
Multiple factors influence conditions of overweight and obesity,
including genetic predisposition, sedentary lifestyles, reduced levels
of physical activity, and food choices (4).
Sugar-sweetened beverages (SSBs) have historically been controver-
sial as risk factors for, or direct contributors to, the development of
obesity because of arguments over study design and other experimen-
tal issues (see (5,6) and references therein). Critical compilation of
data from more recent studies has concluded that SSBs influence or
exaggerate the effect of the principal factors leading to conditions of
overweight and obesity (7,8). Mono- and disaccharides constitute the
major sweeteners in foods and beverages that, when ingested in either
liquid or solid form, influence weight gain and metabolic disease
onset (5,9,10). Sucrose is a disaccharide that supplies glucose and
fructose in equimolar amounts once digested. Glucose metabolism is
subject to regulation through glycolytic pathways, including allosteric
regulation by the enzyme 6-phosphofructo-2 kinase isoform 1,
whereas fructose is phosphorylated by fructokinase and cleaved into
trioses (e.g., by aldolase B), thus bypassing this regulation (11).
Sucrose is a very rewarding stimulus to many organisms and there-
fore is often preferentially sought out (12). Consistent with this idea,
the intake of beverages containing sucrose or other related sweet-
eners has increased dramatically during the past 50 years (7). How-
ever, within 10 weeks, sucrose intake was shown to worsen the met-
abolic profile of human subjects with overweight (13). In addition,
obesogenic diets promote hyperinsulinemia, which could be a con-
tributor to insulin resistance, obesity, or both (14,15).
Because most animal models of obesity exhibit hyperinsulinemia
(16), elevations in circulating insulin could be either a driver or a
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consequence of obesity. Genetic reduction of insulin genes in mice
has revealed that abundant quantities of insulin are indeed required to
support weight gain and increased adiposity during high-fat feeding
(17,18). However, obesity associated with high-fat diet could be dis-
tinct from obesity driven by overconsumption of other macronutrients
(e.g., sucrose); thus, macronutrient imbalance may be sensed by spe-
cific endocrine mechanisms. Fibroblast growth factor 21 (FGF21) is a
protein hormone with wide effects on metabolic outcomes and is thus
poised to participate in nutrient sensing (19). Indeed, there is prece-
dent for elevations in FGF21 during consumption of a low-protein
diet, consistent with a role for macronutrient sensing (20). Because
the Fgf21 gene is also activated in response to elevations in dietary
carbohydrate (21), fasting (22), or glucocorticoids (23), it is reasona-
ble to postulate that a variety of homeostatic mechanisms are acti-
vated by dietary alterations. Our studies herein reveal that C57BL/6J
mice consuming liquid sucrose gain weight without an increase in cir-
culating insulin and display many common features with human sub-
jects who have overweight or obesity.
Methods
Animals and reagents
Sixteen male C57BL6/J (stock no. 000664) mice were obtained from
the Jackson Laboratory (Bar Harbor, Maine) at 8 weeks of age and
allowed free access to Lab Diet 5015 standard nonpurified diet (cata-
log no. 0001328). For comparison with a separate model of obesity,
sixteen male db/db mice (stock no. 000697) were acquired from the
Jackson Laboratory at 8 weeks of age and housed until 14 weeks of
age. All mice were allowed to acclimate to the photoperiod (12 hours
light/12 hours dark) and temperature conditions (228C 6 18C) for at
least 7 days to provide time for normalization of physiological param-
eters due to transport (24). Mice offered a 30% sucrose solution show
a strong preference to this liquid over water (25). Blood glucose was
determined by weekly tail vein sampling using a 25-gauge needle.
Body weight and body composition (by time-domain nuclear mag-
netic resonance) were also measured weekly. Food and liquid intake
was measured daily by weighing the amount provided and subtracting
the mass of the amount consumed over a 24-hour period. Measure-
ments were taken at the same time each day for 2 weeks. Following
a 4-hour fast, animals were sedated by carbon dioxide exposure and
then euthanized by cervical dislocation. For measurements of energy
expenditure (EE), activity, and sleep time, mice were 11 weeks of
age when acclimated to the training cages for 1 week. Thus, they
were 12 weeks of age during the actual measurements. In the meta-
bolic cage, corn cob bedding was included and there was an intake
manifold (a small metal tube that runs along the perimeter of the
cage to pull air). The training cage was exactly the same (bedding,
dimensions, etc.) as the testing cage, minus the manifold on the
perimeter of the cage. Mice were single housed in the training cages
and also in the metabolic cages during measurements. Animals were
allowed continued free access to either standard drinking water (con-
trol group) or 30% sucrose (sucrose group) during metabolic cage
time. All procedures were approved by the University of Tennessee
(protocol 2171-0216) and Pennington Biomedical Research Center
Institutional Animal Care and Use Committee (protocol 972).
Glucose tolerance tests
Glucose tolerance measurements were taken at 3 and 6 weeks into
the 12-week study. Animals in the 30% sucrose group were switched
to standard drinking water overnight prior to glucose tolerance testing,
and the next morning, both groups were placed in clean cages and
fasted for 4 hours before beginning the glucose tolerance test proto-
col. A 20% glucose solution was administered at a concentration of
2.5 g/kg body weight via intraperitoneal injection. Blood glucose was
read prior to injection using a Breeze2 glucometer (Bayer) using tail
vein blood (time 0 minutes) and again at 20, 40, 60, and 120 minutes
after intraperitoneal glucose injection.
Reverse transcription-polymerase chain reaction,
cDNA synthesis, and mRNA analysis
Total RNA was isolated from tissues using the guanidinium thiocya-
nate method (26), complementary DNA (cDNA) was synthesized from
total RNA, and mRNA integrity was analyzed, with mRNA transcripts
measured using the Carbohydrate Metabolism and Regulation of Lipid
Metabolism PrimePCR plates (M384) from Bio-Rad. This strategy
allows for objective screening of key genes encoding enzymes linked
with control of intermediary metabolism. All other primers used
were designed using Primer3Plus software, version 2.4.2 (http://www.
bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) and are available
in Supporting Information Table S1. Normalization procedures to
housekeeping control gene ribosomal protein 9 (Rs9) have been
described (27). Expression was deemed not detectable and given the
label “N.D.” if no expression over baseline was detected by 40 cycles.
Kits and reagents used, and protocols for procedures, have been previ-
ously described (28).
Glycogen and acyl glycerol assays
Total acyl glycerol was measured in rectus abdominis (RA), mixed
gastrocnemius (MG), and liver. Glycogen levels were assessed in
liver and RA tissues. Reagents and protocols for both procedures
have been described in detail elsewhere (15,28).
Serum factors
The following kits were used to measure serum hormones: Mouse/
Rat Leptin Quantikine (catalog no. MOB00) and Mouse/Rat FGF21
Quantikine (catalog no. MF2100) enzyme-linked immunosorbent
assay (ELISA) kits from R&D Systems and the Mouse Insulin
ELISA kit (catalog no. 10-1247-01) from Mercodia, which were
used according to the manufacturers’ suggested protocols.
Pancreatic islet histology
After tissue collection in neutral-buffered formalin, pancreata were
embedded in paraffin. Five-micrometer sections were cut and placed
onto positively charged slides. Insulin-positive area (determined in
square microns) was measured by immunohistochemistry. A complete
description of the methods, equipment, and reagents used for detection
of insulin and quantification of insulin-positive area have been pro-
vided previously (29).
Statistical analysis
One-way analysis of variance (ANOVA) was used when comparing
three or more groups, repeated-measures ANOVA was used for compar-
ing continuous variables, Pearson correlations were calculated to assess
linear associations between two variables, and t tests were performed to
compare two groups with respect to their outcome means. These meas-
ures were conducted using GraphPad Prism software version 6.0.
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GraphPad Prism was used to calculate the area under curve (AUC) for
the glucose tolerance tests. Prism computes AUC using the trapezoid
rule (30). Corresponding P and r values for the respective experiments
are given in figures or figure legends. Analysis of covariance
(ANCOVA) was performed to assess the impact of oxygen consump-
tion (VO2), total body mass (TBM), fat mass (FM), and fat-free mass
(FFM) as covariates on EE. Correlation analyses assessed the magni-
tude of statistical associations among the covariates. Statistical models
were employed to evaluate statistical significance of differences
between sucrose and water with respect to EE, VO2, TBM, FM,
FFM, and lean mass (LM). The SAS statistical software package,
version 9.4, was used to perform the ANCOVA analytic calculations.
Results
Sucrose intake in liquid form alters body
composition and glucose tolerance
Free access to a liquid 30% sucrose solution led to obesity in male
C57BL/6J mice (Figure 1). We found that mice, which were weight
matched at the beginning of the study, began to develop significantly
increased body mass 2 weeks after ad libitum consumption of liquid
sucrose (Figure 1A). This increase in body mass was sustained over the
course of the 12-week period (Figure 1A), with mice consuming sucrose
displaying 39.6% more TBM over the control group (Figure 1B). Mice
drinking water ate similar amounts of solid food (3.51 g/d) compared
with mice drinking sucrose (3.35 g/d). However, mice offered liquid
sucrose consumed more liquid (10.26 g/d) when compared with the water
control group (6.11 g/d), leading to greater caloric intake in the sucrose
group (17.80 kcal/d) relative to the control group (12.97 kcal/d).
LM was enhanced as early as 2 weeks (Figure 1C) in the sucrose group,
with a 40.3% gain over control by the end of the study (Figure 1D). In
addition, FM was elevated within 2 weeks after liquid sucrose consump-
tion (Figure 1E), with a 51% increase in total FM in the sucrose group
relative to the control mice (Figure 1F). The expansion of total FM was
consistent with an increase in epididymal white adipose tissue (eWAT)
weight after 4 weeks of continuous sucrose intake (Figure 1G). We note
that there was no significant change in body length (measured nose to
anus) in response to sucrose consumption (Figure 1H).
Three weeks after sucrose consumption, glucose tolerance was not
significantly altered (Figure 2A-2D). However, by 6 weeks, the
mice consuming sucrose displayed clear alterations in glucose toler-
ance (Figure 2E, raw data, and Figure 2F, normalized data). The
AUC was significantly different for both raw (Figure 2F; P< 0.05)
and normalized values (Figure 2H; P< 0.001).
Elevations in leptin and FGF21, but no change in
serum insulin, in response to liquid sucrose
consumption
During the first week of sucrose drinking, there was no detectable dif-
ference in blood glucose between the mice (Figure 3A). However, by
the end of the study, the mice consuming sucrose displayed a trend
toward increased blood glucose (Figure 3A; 12-week water vs.
sucrose: P 5 0.07). Serum levels of insulin also remained similar
between groups (Figure 3B). Leptin was elevated during the first week
on sucrose (Figure 3C), which was consistent with the early increase
in FM (Figure 1E-1G). However, by the end of the 12-week study,
leptin levels were similar between the sucrose and control groups (Fig-
ure 3C). There was a trend toward increased islet fraction (insulin-pos-
itive area / pancreas area; Figure 3D; P 5 0.11), consistent with a mod-
est increase in insulin-positive area in response to sucrose (Figure 3F).
FGF21, a hormone known to be induced by carbohydrate in vitro (21),
was elevated in vivo in response to sucrose intake (Figure 3E).
Sucrose ingestion increases respiratory quotient,
EE, and caloric intake but does not impact
activity or sleep time
The increase in body mass observed in mice consuming sucrose
(Figure 1) was not due to a decrease in total activity measured
Figure 1 Liquid sucrose consumption promotes weight gain and increases in both lean and fat mass in male C57BL/6J mice. C57BL/6J male mice
were administered either water (gray) or 30% sucrose (black) in their drinking water. (A) Body weight, (C) lean mass (LM), and (E) fat mass (FM) were meas-
ured during the study period. (B) Cumulative weight, (D) LM, and (F) FM gains were calculated for both the water and 30% sucrose groups. (G) Epididymal
white adipose tissue (eWAT) weight after 4 weeks on sucrose and (H) body length at necropsy were measured. Data are shown as means 6 SEM. n 5 8 per
group. *P< 0.05, **P< 0.01, ***P< 0.001 versus respective controls.
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during metabolic cage analyses (Figure 4A). Additionally, average
total sleep time was not different in mice drinking sucrose versus
the control group during the study (Figure 4B). As expected, the
respiratory quotient (RQ) was higher in mice consuming sucrose
(Figure 4C-4D), reflecting an increase in carbohydrate usage.
Despite no differences in physical activity, raw EE (average output
per mouse) was increased by 22% in the group drinking sucrose rel-
ative to mice drinking water (Figure 4E-4F). EE correlated with
TBM (r 5 0.91, P< 0.0001; Figure 5A), FFM (r 5 0.94; P< 0.0001;
Figure 5C), and FM (r 5 0.77; P< 0.001; Figure 5E). By contrast,
VO2 increased moderately as a function of TBM (r 5 0.60;
P< 0.05; Figure 5B) and increased strongly with FFM (r 5 0.75;
P< 0.001; Figure 5D) but not with FM (r 5 0.31; P 5 0.25; Figure
5F). ANCOVA for treatment effects on EE, with TBM, VO2, and
FFM taken as potential covariates for EE, revealed that VO2 was the
most influential single covariate (Supporting Information Table S2).
When the treatment means for EE were covariate adjusted for VO2,
the EE mean for sucrose was significantly elevated (P< 0.025).
When VO2 was held constant in four separate predictive models for
EE that also included LM, TBM, FFM, and FM in turn as an
Figure 3 Sucrose consumption increases circulating leptin and fibroblast growth factor 21 (FGF21), but not insulin. (A)
Blood glucose, (B) serum insulin, and (C) serum leptin were measured in male C57BL/6J mice after 1, 4, or 12 weeks in con-
trol (white bars) versus sucrose (black bars). (D) Islet fraction, (E) circulating levels of FGF21, and (F) insulin-positive area were
assessed. Data are represented as means 6 SEM. n 5 4 per group (1-week study) and n 5 8 per group (12-week study).
*P< 0.05, **P< 0.01.
Figure 2 Chronic consumption of sucrose impairs glucose tolerance in C57BL/6J mice. Glucose tolerance tests (GTTs) were performed at 3 and 6
weeks into the study period. Data are represented as (A,E) raw values or (C,G) normalized data in which the initial time 0 value is set to 100% for both
groups. Area under curve (AUC) calculations for GTTs performed at (B,D) 3 and (F,H) 6 weeks. Data are shown as means 6 SEM. n 5 8 per group.
*P< 0.05, **P< 0.01, ***P< 0.001 versus respective controls.
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additional covariate, each covariate was significantly correlated with
EE. Using linear regression models, we determined that the proportion-
ate amount of total variability in EE that could be attributed to each of
the covariates was 0.827 (TBM), 0.590 (FM), and 0.882 (FFM), respec-
tively. However, when VO2 and TBM were simultaneously held con-
stant, the other covariates being considered were not significant contrib-
utors to the prediction of EE (Supporting Information Table S2).
Lipid, but not glycogen, storage increases in liver
during sucrose consumption
Total acyl glycerol accumulation was augmented in liver tissue start-
ing 1 week after sucrose consumption (Figure 6A) and remained ele-
vated over control at 12 weeks (Figure 6A). By contrast, liver glyco-
gen storage was not impacted by either acute (1 week) or chronic (12
weeks) sucrose consumption (Figure 6B). Several genes involved in
Figure 4 Sucrose increases energy expenditure (EE) and respiratory quotient (RQ) but does alter activity or sleep time. Mice were accli-
mated to drinking water or a 30% sucrose solution for 1 week prior to placement in metabolic cages. (A) Total activity and (B) mean sleep time
during access to either water (white bars) or sucrose (black bars). (C) RQ at daily intervals showing light cycle (white) and dark cycle (gray). (D)
Average RQ across all time points. (E) EE at daily intervals showing the light and dark cycles. (F) Average EE over a 5-day period. n 5 8 per
group. ***P< 0.001 versus water.
Figure 5 Increased oxygen consumption (VO2) in response to sucrose intake correlates strongly with fat-free mass.
Energy expenditure (EE) expressed as a function of (A) total body mass (TBM), (C) fat-free mass (FFM), and (E) fat mass (FM)
in mice consuming either water (gray circles) or sucrose (black squares). VO2 shown in relationship to (B) TBM (epididymal
white adipose tissue), (D) FFM, and (F) FM. n 5 8 in each group.
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carbohydrate processing were expressed more robustly at both acute
and chronic time points (Figure 6C-6D). For example, aldolase B
(AldoB) was elevated more than threefold in the sucrose group rela-
tive to the control group after 1 week (Figure 6C). AldoB encodes the
liver form of the enzyme, which catalyzes the reversible cleavage of
fructose 1,6-bisphosphate into glyceraldehyde 3-phosphate and dihy-
droxyacetone phosphate as well as the bidirectional fragmentation of
fructose 1-phosphate into glyceraldehyde and dihydroxyacetone phos-
phate. The AldoB gene remained highly expressed at 12 weeks post
sucrose (> 4-fold; Figure 6D). In addition, aldolase C (AldoC), which
is normally expressed in the central nervous system, was upregulated
approximately 19-fold by 12 weeks (Figure 6D), which likely reflects
the need to process the abundance of carbohydrates being ingested.
Consistent with carbohydrate conversion to lipid as a storage form,
the genes encoding acetyl-coenzyme A carboxylase (Acaca), fatty
acid synthase (Fasn), and microsomal triglyceride transfer protein
(Mttp) were all elevated in mice consuming sucrose relative to con-
trols (Figure 6E). Genes in the serpin class encode protease inhibi-
tors that regulate a variety of biological processes, including inflam-
mation. We found that the serpin family A member 12 (SerpinA12,
also known as vaspin) gene was selectively expressed more than 12-
fold in the livers of mice consuming sucrose (Figure 6F).
Sucrose enhances expression of genes
associated with lipid metabolism in eWAT but
does not promote lipid or glycogen storage in
skeletal muscle
Because of the increase in LM observed in response to sucrose con-
sumption (Figure 1C), we examined both lipid and glycogen content in
skeletal muscle. Using RA and MG, we found that although MG con-
tained, more total acyl glycerols when compared with RA, neither RA
nor MG displayed elevated triglycerides in response to sucrose intake
(Figure 7A). Although glycogen content increased with age in RA mus-
cle of control mice (compare 1 week with 12 weeks; white bars), the
group drinking sucrose did not accumulate glycogen over time (Figure
7B). Although surprising at first glance, these results in mice are similar
to those observed in humans, in whom muscle glycogen is reduced for
subjects with obesity and type 2 diabetes (31). We also observed that
there were minimal changes in expression of glycolytic enzyme genes in
RA muscle after 1 week on sucrose (Figure 7C). However, by 12 weeks,
there was a marked increase in genes encoding glycolytic enzymes,
including upregulation of phosphoglycerate mutase 1 (Pgam1), pyruvate
kinase, muscle (Pkm), and glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) (Figure 7D).
When examining the eWAT from mice consuming sucrose versus
controls, most genes encoding glycolytic enzymes were either
unchanged or trending toward decreased expression (Figure 7E-7F).
By contrast, several genes that regulate lipid metabolism were dis-
tinctly upregulated. For example, expression of carnitine
palmitoyltransferase-1b (Cpt1b), which encodes an enzyme involved
in fatty acid oxidation, was increased threefold in eWAT in response
to sucrose (Figure 7G). However, fatty acid binding protein 7, brain
(Fabp7) and fatty acid binding protein 1, liver (Fabp1) were selec-
tively expressed at higher levels ( 5-fold) in mice ingesting sucrose
relative to controls (Figure 7G).
Differential pattern of gene expression in inguinal
white adipose tissue from mice consuming
sucrose when compared with inguinal white
adipose tissue from genetically obese db/db mice
We next compared expression of the cell death-inducing DNA frag-
mentation factor, alpha subunit-like effector A (Cidea) and uncoupling
Figure 6 Liver lipid, but not glycogen, content is increased by liquid sucrose consumption. (A) Total acyl glycerol and (B)
glycogen content was measured using liver tissue from male C57BL/6J mice consuming either water or sucrose. Expression
of genes relating to carbohydrate metabolism was quantified using RNA isolated from liver in the (C) 1-week and (D) 12-week
studies. Total mRNA abundance of (E) lipogenic and (F) serpin genes were determined in liver tissue. Data in panels C, D,
and F are represented as a ratio of expression in 30% sucrose group versus water group. Data are shown as means 6 SEM.
n 5 8 per group (A,B,E) or n 5 3 per group (C,D,F). *P< 0.05, **P< 0.01 versus respective controls.
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protein 1 (Ucp1) genes, which often indicate browning of white adi-
pose tissue, using the inguinal white adipose tissue (iWAT) depots
from two different models of obesity: mice consuming sucrose for 12
weeks in liquid form versus db/db mice, a genetic model of obesity
produced by a defect in leptin receptor signaling. We found that the
expression of Ucp1 and Cidea genes were elevated 28- and 15-fold,
respectively, in response to sucrose consumption (Figure 8A). By con-
trast, expression of Ucp1 was undetectable in iWAT from db/db mice
(Figure 8B). Although Cidea was clearly increased in mice drinking
sucrose, expression of this gene decreased in db/db mice relative to the
lean controls (Figure 8B). Next, we observed that expression of nucle-
otide-binding oligomerization domain containing 1 (Nod1) was
reduced by 89% in mice consuming sucrose (Figure 8C). This is inter-
esting because NOD1 restricts adipocyte differentiation (32); thus, a
decrease in its expression would be expected to allow the expansion of
adipose tissue, consistent with what was observed during sucrose
intake (Figure 1). We observed that neither db/db mice nor the lean
control mice (db/1) expressed appreciable amounts of Nod1 tran-
scripts in iWAT (Figure 8D).
Expression of Adipoq, encoding the hormone adiponectin, was
decreased in both the sucrose model of obesity and in db/db mice
(Figure 8C-8D). In addition, serum amyloid A 3 (Saa3) was
expressed at lower levels in sucrose-consuming mice (Figure 8E)
Figure 7 Sucrose increases expression of genes linked with carbohydrate metabolism in skeletal muscle and expression of genes controlling lipid
metabolism in epididymal white adipose tissue (eWAT). (A) Total acyl glycerol and (B) glycogen content was measured in the rectus abdominis and mixed
gastrocnemius (MG) muscle depots from male C57BL/6J mice. Expression of genes involved in carbohydrate metabolism was determined in (C,D) rectus
muscle and (E,F) eWAT. Data in panels C-F are represented as a ratio of expression of the 30% sucrose group versus water group (dashed line indicates
expression of water control group). (G) Total mRNA abundance of genes regulating lipid metabolism was studied in the eWAT from mice on an oral 30%
sucrose regimen. Data are shown as means 6 SEM. n 5 8 per group (A,B,G) or n 5 3 per group (C-F). **P< 0.01 versus respective controls.
Figure 8 Distinct differences in gene expression profiles in inguinal white adipose tissue (iWAT) from obese db/db mice compared with C57BL/6J mice made obese by liq-
uid sucrose intake. Relative mRNA abundance of genes expressed in iWAT from either C57BL/6J mice drinking either 30% sucrose or water (A,C,E,G,I) versus 14-week-old db/
1 and db/db mice (B,D,F,H,J). Data are plotted as means6SEM. n5 8 per group. *P< 0.05, **P< 0.01, ****P< 0.0001 versus respective controls. N.D. 5 not detectable.
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but was strikingly increased in expression in db/db mice (Figure
8F). In addition, the macrophage marker Cd68 was expressed at
lower levels in obesity driven by sucrose (Figure 8E) but was
unchanged in db/db mice relative to controls (Figure 8F).
Adipose tissue expression of vascular endothelial growth factors
(VEGFs) modulates insulin resistance during high-fat feeding (33).
Indeed, the metabolic benefits of intermittent fasting require VEGF,
which may be in part through effects on macrophage polarization
(34). Weight gain induced by sucrose intake was associated with a
93% decrease in expression of Vegfa and an 88% reduction in Vegfb
mRNA levels (Figure 8G). In adipose tissue of db/db mice (relative
to the lean controls), the expression of Vegfa increased by 2.3-fold,
whereas Vegfb transcripts declined by 56% (Figure 8H).
Diacylglycerol acyltransferases, encoded by the Dgat1 and Dgat2
genes, catalyze the final step in triglyceride synthesis. We found
that expression of Dgat1 and Dgat2 were reduced by 92% and 97%,
respectively, in the iWAT from mice drinking sucrose (Figure 8I).
However, the expression of these genes was unchanged between
lean db/ 1 and obese db/db mice (Figure 8J).
Discussion
Caloric overload in its various forms (e.g., high-fat diet, SSBs),
coupled with sedentary lifestyle, are major contributors to the rising
rates of obesity. Indeed, nutrient excess from SSBs has increased
substantially over the past 50 1 years (7), likely contributing to the
rising prevalence of metabolic disease (8). In the present study, we
provided male C57BL/6J mice with free access to a 30% sucrose
solution to investigate the specific metabolic consequences that
occur in response to liquid sugar intake. Because all mice had access
to the same solid chow diet, major metabolic differences between
groups were able to be directly compared. One of the key findings
herein is that changes in body composition precede changes in glu-
cose tolerance.
Humans with a high 24-hour RQ are more likely to show weight
gain than those with a low RQ (35). Consistent with these results,
we found that C57BL/6J mice consuming liquid sucrose consistently
had higher RQ values (Figure 4C-4D) and that these mice gained
more weight (Figure 1). However, elevated levels of insulin were
clearly not required to achieve this enhanced body mass in response
to liquid sucrose consumption (Figure 3B). These data provide an
intriguing difference between obesity induced by a high-fat diet, in
which insulin levels rise (15,36), and adiposity driven by liquid
sucrose. Thus, whether insulin is simply permissive for weight gain
or is a direct contributor to weight gain may be dependent on die-
tary context (i.e., precise macronutrient intake).
When adiposity decreases, there are corresponding reductions in cir-
culating insulin (37). Interestingly, mice with genetic deletion of
multiple copies of the insulin gene resist weight gain on a high-fat
diet (17), indicating that a threshold level of insulin may be required
to support adiposity and elevations in TBM in response to excess
dietary lipid. Because elevations in circulating insulin are not
required to promote weight gain or deposition of adipose tissue dur-
ing ad libitum access to liquid sucrose, we interpret these data to
indicate that excess carbohydrate intake is a particularly potent
factor supporting weight gain. Thus, under certain conditions (e.g.,
free consumption of SSBs), the amount of basal insulin present in
circulation is likely sufficient to route the excess substrate into lipid
storage and/or to adequately suppress fatty acid oxidation in favor
of carbohydrate oxidation, resulting in higher RQ values and subse-
quent weight gain. A separate but not mutually exclusive possibility
is that calories consumed in liquid versus solid form may elicit dis-
tinct endocrine responses in mice, consistent with observations in
humans (38).
Intriguingly, glycogen content of liver (Figure 6B) and muscle (Fig-
ure 7B) was not elevated by sucrose consumption, whereas liver
lipid content was increased (Figure 6A). Expression of the Ser-
pinA12 gene, which is linked with obesity and type 2 diabetes (39),
was upregulated in livers of mice consuming sucrose (Figure 6F).
Although insulin-positive area was modestly enhanced by sucrose
consumption (Figure 3F), islet fraction was unaltered (Figure 3D).
By contrast, excess lipid in the diet promotes enlarged pancreatic b-
cell mass, generally resulting from enhanced b-cell proliferation
within the islets (40).
Perhaps greater circulating FGF21 levels serve as an insulin
“sensitizing” signal or as a feedback loop to prevent excess weight
gain by increasing EE (Figure 4E). Indeed, augmented FGF21 in cir-
culation promotes browning of white adipose tissue (see reference
(41) and Figure 8A), which often correlates with enhanced EE (see
Figure 4E-4F and reference (42)). Importantly, our results using
C57BL/6J mice consuming sucrose are analogous to human studies
showing that EE increased specifically in subjects ingesting a
sucrose-rich diet (43). However, two limitations of our study are that
we did not use clamp techniques to determine whether the lipid accu-
mulation in liver prevents the normal suppression of hepatic glucose
production by insulin, and we did not study obesity driven by sucrose
in female mice. These are important considerations for future studies.
In summary, sucrose intake promotes weight gain and adiposity with
distinct metabolic differences when compared with the db/db mouse
model of obesity. From a translational perspective, the data in this
study agree with human studies in several aspects. First, sucrose
intake rapidly promotes greater weight gain and increased FM in
mice (Figure 1) and humans (13). Second, EE is greater in mice
(Figure 4E) and humans consuming sucrose (43). Third, elevations
in RQ are associated with weight gain in mice (Figure 4C) and
humans (35). Fourth, sucrose promotes lipid accumulation in liver
of mice (Figure 6A), rats (44), and humans (45). In summary, we
conclude that male C57BL/6J mice consuming liquid sucrose pro-
vide a model of obesity and glucose intolerance with key physio-
logic features that are relevant to human metabolic disease.O
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